Ardelyx (ARDX) Other Working Capital Changes (2013 - 2026)
Ardelyx (ARDX) reported Other Working Capital Changes of $2.0 million for Q1 2026, up 271.45% on a YoY basis from $549733.7 in Q1 2025, and up 232.68% quarter-over-quarter from -$1.5 million in Q4 2025.
Ardelyx (ARDX) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Ardelyx has reported Other Working Capital Changes for 14 years, with the latest figure at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 271.45% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $220000.0 (up 104.84% YoY), and the FY2025 full-year result was -$3.0 million, down 244.02% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $2.0 million, up from -$1.5 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $6.4 million in Q3 2024, with the low at -$7.6 million in Q2 2024.
- Historically, Other Working Capital Changes has averaged $258588.2 across 5 years, with a median of $609000.0 in 2025.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes soared 386.46% — and 2024, when it tumbled 2522.22%.
- Ardelyx's Other Working Capital Changes stood at $1.4 million in 2022, then plunged by 105.63% to -$81000.0 in 2023, then plunged by 2522.22% to -$2.1 million in 2024, then rose by 27.54% to -$1.5 million in 2025, then soared by 232.68% to $2.0 million in 2026.
- The last three Other Working Capital Changes figures came in at $2.0 million (Q1 2026), -$1.5 million (Q4 2025), and $609000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | -1.54 Mn |
| Dec 31, 2025 | -1.54 Mn |
| Sep 30, 2025 | 609,000.00 |
| Sep 30, 2025 | 609,000.00 |
| Jun 30, 2025 | -892,000.00 |
| Jun 30, 2025 | -892,000.00 |
| Mar 31, 2025 | -1.19 Mn |
| Mar 31, 2025 | -1.19 Mn |
| Dec 31, 2024 | -2.12 Mn |
| Dec 31, 2024 | -2.12 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Jun 30, 2024 | -7.65 Mn |
| Jun 30, 2024 | -7.65 Mn |
| Mar 31, 2024 | 5.45 Mn |
| Mar 31, 2024 | 5.45 Mn |
| Dec 31, 2023 | -81,000.00 |
| Dec 31, 2023 | -81,000.00 |